UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038906
Receipt number R000040655
Scientific Title Photodynamic diagnosis involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in surveillance of non muscle invasive bladder cancer
Date of disclosure of the study information 2019/12/16
Last modified on 2022/06/23 11:44:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Photodynamic diagnosis involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in surveillance of non muscle invasive bladder cancer

Acronym

Photodynamic diagnosis using hexaminolevulinate in surveillance of non-muscle invasive bladder cancer

Scientific Title

Photodynamic diagnosis involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in surveillance of non muscle invasive bladder cancer

Scientific Title:Acronym

Photodynamic diagnosis using hexaminolevulinate in surveillance of non-muscle invasive bladder cancer

Region

Japan


Condition

Condition

bladder cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Comparison with the findings on cystoscopy and the results of photodynamic diagnosis using hexaminolevulinate

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison with the findings on cystoscopy and the results of photodynamic diagnosis using hexaminolevulinate every three months after transurethral resection of bladder cancer

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 patients with non muscle invasive bladder cancer confirmed by transurethral resection
2 patients aged 20 and over
3 patients who plan to commute Nara Medical University for follow-up.

Key exclusion criteria

1 patients who received cystectomy
2 patients without informed consent

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Nakai

Organization

Nara Medical University

Division name

Department of Urology

Zip code

634-8521

Address

Shijyocho 840

TEL

0744223051

Email

nakaiyasusiuro@live.jp


Public contact

Name of contact person

1st name Yasushi
Middle name
Last name Nakai

Organization

Nara Medical University

Division name

Department of Urology

Zip code

634-8521

Address

Shijyocho 840

TEL

0744223051

Homepage URL


Email

nakaiyasusiuro@live.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the ethics committee of Nara Medical university

Address

Shijyocho 840, Kashihara, Nara

Tel

0744223051

Email

nakaiyasusiuro@live.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

162

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 20 Day

Date of IRB

2019 Year 04 Month 01 Day

Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2019 Year 12 Month 16 Day

Last modified on

2022 Year 06 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040655


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name